← Open Payments lookup

CLAUDIA UKPOLO: Open Payments

NPI 1811303829 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$329 in 12 payments from 9 companies in 2025. Trend: 2023 $703 · 2024 $512 · 2025 $329

Food & beverage: $329
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$83
Collegium Pharmaceutical, Inc.1$63
Supernus Pharmaceuticals, Inc.1$45
ABBVIE INC.2$43
Axsome Therapeutics, Inc.1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Teva Pharmaceuticals USA, Inc.1$17
Currax Pharmaceuticals LLC1$16
Indivior Inc.1$15

Products named: INGREZZA, Jornay PM, Qelbree, VRAYLAR, Auvelity, CAPLYTA, UZEDY, ONZETRA XSAIL.

Industry payments across LA — which companies pay providers there.